Autoresearch: Constellation Energy (CEG) Nuclear Thesis Update — June 2026

Generated by /autoresearch on 2026-06-01. 1 round, 3 URLs. Context: vault/projects/stock-market.

Summary

CEG Q1 2026 beat expectations (EPS $2.74, revenue up 64% YoY), reaffirmed full-year guidance of $11–12/share adjusted EPS. Stock is ~$300 as of May 12 — up from $287.75 on May 29 dispatch. PJM framework targeting FERC June 2026 submission (near-term catalyst). New risk surfaced: Calpine lockup expiry June 30, 2026 — 25M shares of potential supply overhang. US Government ordered PA nuclear plants to keep running (grid reliability order). TIKR model price target $569 (~90% upside from $300).

Findings

Q1 2026 earnings: strong beat, guidance reaffirmed

• Revenue: $11.1B, up 64% YoY (primarily Calpine acquisition consolidation). (TIKR)
• Adjusted EPS: $2.74 (vs $2.14 Q1 2025); GAAP EPS $4.49.
• Full-year guidance: $11–12 adjusted EPS — reaffirmed.
• Nuclear capacity factor: 92.3%, generating 40 million MWh in Q1.
• New capacity submitted to PJM interconnection queue: ~5,000 MW (nuclear uprates + gas + storage).

PJM near-term catalysts

• PJM framework to FERC: Management stated PJM is targeting June 2026 submission — provides "critical clarity for large load customers evaluating colocated data center projects."
• Hyperscaler spending: +75% YoY projected; data center power delivery expected to energize in Q4 2026.
• This FERC submission is the gate for new hyperscaler large-load PPAs (the next leg of the nuclear baseload thesis).
• Meta PPA: agreement to keep one Illinois nuclear reactor operating for 20 more years. (Finviz)

US Government grid reliability order: nuclear as strategic asset

• US Government ordered Constellation Energy to keep its Pennsylvania nuclear plants running for grid reliability — treating nuclear as critical infrastructure. (TIKR)
• This is a structural moat signal: Constellation can't easily be replaced, and government intervention validates the grid-reliability premium.

NEW RISK: Calpine lockup expiry June 30, 2026

• Calpine lockup expiry June 30, 2026 → up to 25 million shares of potential supply overhang.
• This is 14 days from today and not in the May 30 dispatch analysis.
• Q1's 21% EBIT margin may reflect seasonal factors, not a sustainable baseline.
• The lockup expiry could suppress stock near-term (through late July) — this is the entry window if the thesis is intact.

Valuation context

• Stock: ~$300 (May 12 data; up from $287.75 on May 29 dispatch).
• TIKR model price target: $569 (~90% upside at $300).
• 52w high was ~$412.70 — still -27% from peak at $300.
• Base case thesis: PJM capacity auction 10× + nuclear PPA pipeline + Calpine gas PPA cross-sell.

Contradictions and open questions

1. Calpine lockup expiry June 30: 25M share overhang could suppress CEG from $300 into late July. Is the entry window opening? The thesis says "buy at -30% from 52w high" — we're at -27% from $412 at $300. If lockup creates selling, could see $270-280 range.
2. PJM FERC June submission: If FERC delays or the submission is rejected, hyperscaler PPA conversion stalls into Q4 → bull case timeline extends.
3. TMI 2031 delay: Not new, but the interconnection delay risk is still live. No new update found.

Provenance

URLs fetched:

• TIKR — CEG Q1 2026 earnings
• TIKR — US Govt PA nuclear order
• Finviz — CEG PJM developments

Generated: 2026-06-01